Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still’s Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience

INTRODUCTION: Patients with adult-onset Still’s disease (AOSD) are at risk of developing macrophage activation syndrome (MAS), a life-threatening condition. Some cases of MAS have been reported following the use of biological agents, highlighting the need to identify contributing factors. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Adachi, Soichiro, Takase-Minegishi, Kaoru, Maeda, Ayaka, Nagai, Hideto, Horita, Nobuyuki, Yoshimi, Ryusuke, Kirino, Yohei, Nakajima, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654298/
https://www.ncbi.nlm.nih.gov/pubmed/37794210
http://dx.doi.org/10.1007/s40744-023-00600-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654298/
https://www.ncbi.nlm.nih.gov/pubmed/37794210
http://dx.doi.org/10.1007/s40744-023-00600-x

Ejemplares similares